Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.Microsurgery|August 9, 2001
Syngeneic consecutive rat spleen transplantation bearing infantile testisS Lee, C H Yoo, I C Hong, et al.Cancer Research|October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step processN Craft, C Chhor, C Tran, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinomaA Hinkel, C L Tso, B J Gitlitz, et al.The Journal of Urology|November 1, 1993
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinomaA Belldegrun, W Pierce, R Kaboo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinomaP Mulders, C L Tso, S Pang, et al.Transplantation|January 15, 1997
Sequential isologous organ transplantation in inbred rats: pancreaticoduodenal transplantsS Lee, M D'Silva, Y Wang, et al.Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factorsL D Petz, L Calhoun, P Yam, et al.The Journal of Urology|November 1, 1996
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patientsM H Sokoloff, C L Tso, R Kaboo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacyP J Rosen, E F Mendoza, E M Landaw, et al.Pageof 19